Literature DB >> 31186856

Hepatitis C viral infection in incarcerated patients.

John Rice1, Lisa Cervantes1, Michael R Lucey1.   

Abstract

Entities:  

Year:  2012        PMID： 31186856      PMCID： PMC6499266          DOI： 10.1002/cld.47

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  13 in total

Review 1.  A framework for management of hepatitis C in prisons.

Authors:  Anne C Spaulding; Cindy M Weinbaum; Daryl T-Y Lau; Richard Sterling; Leonard B Seeff; Harold S Margolis; Jay H Hoofnagle
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

2.  Access to treatment of hepatitis C in prison inmates.

Authors:  Paul Strock; Joël Mossong; Karine Hawotte; Vic Arendt
Journal:  Dig Dis Sci       Date:  2008-08-29       Impact factor: 3.199

3.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Psychiatric disorders and repeat incarcerations: the revolving prison door.

Authors:  Jacques Baillargeon; Ingrid A Binswanger; Joseph V Penn; Brie A Williams; Owen J Murray
Journal:  Am J Psychiatry       Date:  2008-12-01       Impact factor: 18.112

6.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

7.  Treatment of chronic hepatitis C in a state correctional facility.

Authors:  Scott A Allen; Anne C Spaulding; Albert M Osei; Lynn E Taylor; Asya M Cabral; Josiah D Rich
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

8.  Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?

Authors:  Richard K Sterling; Charlotte M Hofmann; Velimir A Luketic; Arun J Sanyal; Melissa J Contos; A Scott Mills; Mitchell L Shiffman
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

9.  Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention.

Authors:  Cindy Weinbaum; Rob Lyerla; Harold S Margolis
Journal:  MMWR Recomm Rep       Date:  2003-01-24

10.  Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.

Authors:  Duncan Smith-Rohrberg Maru; Robert Douglas Bruce; Sanjay Basu; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.